305 related articles for article (PubMed ID: 12456664)
1. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases.
Suzuki T; Suzuki T; Wada T; Saigo K; Watanabe K
EMBO J; 2002 Dec; 21(23):6581-9. PubMed ID: 12456664
[TBL] [Abstract][Full Text] [Related]
2. Novel taurine-containing uridine derivatives and mitochondrial human diseases.
Suzuki T; Suzuki T; Wada T; Saigo K; Watanabe K
Nucleic Acids Res Suppl; 2001; (1):257-8. PubMed ID: 12836362
[TBL] [Abstract][Full Text] [Related]
3. Role of taurine in the pathologies of MELAS and MERRF.
Schaffer SW; Jong CJ; Ito T; Azuma J
Amino Acids; 2014 Jan; 46(1):47-56. PubMed ID: 23179085
[TBL] [Abstract][Full Text] [Related]
4. Human mitochondrial diseases caused by lack of taurine modification in mitochondrial tRNAs.
Suzuki T; Nagao A; Suzuki T
Wiley Interdiscip Rev RNA; 2011; 2(3):376-86. PubMed ID: 21957023
[TBL] [Abstract][Full Text] [Related]
5. Human mitochondrial diseases associated with tRNA wobble modification deficiency.
Kirino Y; Suzuki T
RNA Biol; 2005 Apr; 2(2):41-4. PubMed ID: 17132941
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases.
Umeda N; Suzuki T; Yukawa M; Ohya Y; Shindo H; Watanabe K; Suzuki T
J Biol Chem; 2005 Jan; 280(2):1613-24. PubMed ID: 15509579
[TBL] [Abstract][Full Text] [Related]
7. Wobble modification deficiency in mutant tRNAs in patients with mitochondrial diseases.
Yasukawa T; Kirino Y; Ishii N; Holt IJ; Jacobs HT; Makifuchi T; Fukuhara N; Ohta S; Suzuki T; Watanabe K
FEBS Lett; 2005 May; 579(13):2948-52. PubMed ID: 15893315
[TBL] [Abstract][Full Text] [Related]
8. Posttranscriptional modifications in mitochondrial tRNA and its implication in mitochondrial translation and disease.
Kazuhito T; Wei FY
J Biochem; 2020 Nov; 168(5):435-444. PubMed ID: 32818253
[TBL] [Abstract][Full Text] [Related]
9. Chemical synthesis of the 5-taurinomethyl(-2-thio)uridine modified anticodon arm of the human mitochondrial tRNA(Leu(UUR)) and tRNA(Lys).
Leszczynska G; Leonczak P; Wozniak K; Malkiewicz A
RNA; 2014 Jun; 20(6):938-47. PubMed ID: 24757169
[TBL] [Abstract][Full Text] [Related]
10. Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease.
Asano K; Suzuki T; Saito A; Wei FY; Ikeuchi Y; Numata T; Tanaka R; Yamane Y; Yamamoto T; Goto T; Kishita Y; Murayama K; Ohtake A; Okazaki Y; Tomizawa K; Sakaguchi Y; Suzuki T
Nucleic Acids Res; 2018 Feb; 46(4):1565-1583. PubMed ID: 29390138
[TBL] [Abstract][Full Text] [Related]
11. Decoding property of C5 uridine modification at the wobble position of tRNA anticodon.
Kurata S; Ohtsuki T; Wada T; Kirino Y; Takai K; Saigo K; Watanabe K; Suzuki T
Nucleic Acids Res Suppl; 2003; (3):245-6. PubMed ID: 14510472
[TBL] [Abstract][Full Text] [Related]
12. Chemical synthesis and properties of 5-taurinomethyluridine and 5-taurinomethyl-2-thiouridine.
Ogata T; Shimazaki T; Umemoto T; Kurata S; Ohtsuki T; Suzuki T; Wada T
J Org Chem; 2009 Mar; 74(6):2585-8. PubMed ID: 19219973
[TBL] [Abstract][Full Text] [Related]
13. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease.
Kirino Y; Goto Y; Campos Y; Arenas J; Suzuki T
Proc Natl Acad Sci U S A; 2005 May; 102(20):7127-32. PubMed ID: 15870203
[TBL] [Abstract][Full Text] [Related]
14. mt-tRNA components: synthesis of (2-thio)uridines modified with blocked glycine/taurine moieties at C-5,1.
Leszczynska G; Leonczak P; Dziergowska A; Malkiewicz A
Nucleosides Nucleotides Nucleic Acids; 2013; 32(11):599-616. PubMed ID: 24138499
[TBL] [Abstract][Full Text] [Related]
15. Taurine-containing uridine modifications in tRNA anticodons are required to decipher non-universal genetic codes in ascidian mitochondria.
Suzuki T; Miyauchi K; Suzuki T; Yokobori SI; Shigi N; Kondow A; Takeuchi N; Yamagishi A; Watanabe K
J Biol Chem; 2011 Oct; 286(41):35494-35498. PubMed ID: 21873425
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content.
Jong CJ; Ito T; Mozaffari M; Azuma J; Schaffer S
J Biomed Sci; 2010 Aug; 17 Suppl 1(Suppl 1):S25. PubMed ID: 20804600
[TBL] [Abstract][Full Text] [Related]
17. Defective Mitochondrial tRNA Taurine Modification Activates Global Proteostress and Leads to Mitochondrial Disease.
Fakruddin M; Wei FY; Suzuki T; Asano K; Kaieda T; Omori A; Izumi R; Fujimura A; Kaitsuka T; Miyata K; Araki K; Oike Y; Scorrano L; Suzuki T; Tomizawa K
Cell Rep; 2018 Jan; 22(2):482-496. PubMed ID: 29320742
[TBL] [Abstract][Full Text] [Related]
18. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.
Kirino Y; Yasukawa T; Ohta S; Akira S; Ishihara K; Watanabe K; Suzuki T
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15070-5. PubMed ID: 15477592
[TBL] [Abstract][Full Text] [Related]
19. Decoding mechanism of non-universal genetic codes in Loligo bleekeri mitochondria.
Ohira T; Suzuki T; Miyauchi K; Suzuki T; Yokobori SI; Yamagishi A; Watanabe K
J Biol Chem; 2013 Mar; 288(11):7645-7652. PubMed ID: 23362261
[TBL] [Abstract][Full Text] [Related]
20. Human mitochondrial tRNAs: biogenesis, function, structural aspects, and diseases.
Suzuki T; Nagao A; Suzuki T
Annu Rev Genet; 2011; 45():299-329. PubMed ID: 21910628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
